Large Shareholding Report Form Submitted (No Specifics)
This document is a standard form for a large shareholding status report, but no actual shareholding numbers or changes are provided.
Financial data of two HLB subsidiaries (HLB Therapeutics, HLB Life Science) are included: total assets 478B won/135.8B won, total liabilities 180.3B won/81B won respectively.